MTOR and central nervous system cancer: The report from Chen indicated that PD-L1 modulated immune cell infiltration in glioma microenvironment (TME) and served as signaling protein control multiple pathways including STAT3, PI3K/AKT/mTOR, Ras/ERKsignaling pathways [126].